News
Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...
People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...
In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...
A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...
A new low-cost generic form of Tecfidera is available in the U.S. for people with relapsing forms of MS for a fraction of the ...
Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...
Celebrating independence can be important when living with multiple sclerosis, columnist Ben Hofmeister writes.
Heat sensitivity makes July 4 columnist Leigh Anne Nelson's least favorite holiday. This year, she'll be listening to her ...
A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results